This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
Annals of Hematology Open Access 30 January 2020
-
Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway
Nature Communications Open Access 11 December 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sperling AS, Gibson CJ, Ebert BL . The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer 2017; 17: 5–19.
Adams PD, Jasper H, Rudolph KL . Aging-induced stem cell mutations as drivers for disease and cancer. Cell Stem Cell 2015; 16: 601–612.
Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 2014; 371: 2488–2498.
Genovese G, Kähler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 2014; 371: 2477–2487.
Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med 2014; 20: 1472–1478.
Brosh R, Rotter V . When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 2009; 9: 701–713.
Lindsley RC, Ebert BL . Molecular pathophysiology of myelodysplastic syndromes. Annu Rev Pathol 2013; 8: 21–47.
Rücker FG, Schlenk RF, Bullinger L, Kayser S, Teleanu V, Kett H et al. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood 2012; 119: 2114–2121.
Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD et al. Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation. N Engl J Med 2017; 376: 536–547.
Wlodarski P, Wasik M, Ratajczak MZ, Sevignani C, Hoser G, Kawiak J et al. Role of p53 in hematopoietic recovery after cytotoxic treatment. Blood 1998; 91: 2998–3006.
Liu Y, Elf SE, Miyata Y, Sashida G, Liu YH, Huang G et al. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009; 4: 37–48.
Bondar T, Medzhitov R . p53-mediated hematopoietic stem and progenitor cell competition. Cell Stem Cell 2010; 6: 309–322.
Wong TN, Ramsingh G, Young AL, Miller CA, Touma W, Welch JS et al. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature 2015; 518: 552–555.
Song H, Hollstein M, Xu Y . p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat Cell Biol 2007; 15: 376–388.
Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 2014; 506: 328–333.
Beerman I, Rossi DJ . Epigenetic control of stem cell potential during homeostasis, aging, and disease. Cell Stem Cell 2005; 16: 613–625.
Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, Crowley D, Jacks T . Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 2004; 119: 847–860.
Kemp CJ, Wheldon T, Balmain A . p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet 1994; 8: 66–69.
Acknowledgements
This work was supported in part by a NIH/NIA R56 award R56AG052501, a Department of Defense (DoD) Grant W81XWH-13-1-0187, a Career Development Award from the St. Baldrick’s Foundation, an Elsa Pardee Foundation New Investigator Award, a Leukemia Research Foundation New Investigator Award, a Showalter Trust Fund New Investigator Award, an Alex Lemonade Stand Foundation grant, a Children’s Leukemia Research Association grant and an American Cancer Society Institutional Research Grant to YL. We thank the Flow Cytometry Core and In vivo Therapeutic Core Laboratories, which were sponsored, in part, by the NIDDK Cooperative Center of Excellence in Hematology (CCEH) grant U54 DK106846. This work was supported, in part, by a Project Development Team within the ICTSI NIH/NCRR Grant Number UL1TR001108. We also thank Dr. Yang Xu at USCD for providing the p53R248W mice to the study.
Author contributions
SC and YL designed the research. SC, RG, CY, MK and SZL performed the research. SC and YL analyzed the data and performed the statistical analysis. MCY, HB, RK, HSB and LDM provided reagents and/or input to the study. SC and YL wrote the manuscript. All authors read, commented on and approved the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Chen, S., Gao, R., Yao, C. et al. Genotoxic stresses promote clonal expansion of hematopoietic stem cells expressing mutant p53. Leukemia 32, 850–854 (2018). https://doi.org/10.1038/leu.2017.325
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.325
This article is cited by
-
Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?
Stem Cell Reviews and Reports (2020)
-
TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
Annals of Hematology (2020)
-
Mutant p53 enhances leukemia-initiating cell self-renewal to promote leukemia development
Leukemia (2019)
-
Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway
Nature Communications (2019)